Edgestream Partners L.P. Acquires 24,819 Shares of Integer Holdings Corporation (NYSE:ITGR)

Edgestream Partners L.P. raised its position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 208.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 36,729 shares of the medical equipment provider's stock after acquiring an additional 24,819 shares during the period. Edgestream Partners L.P. owned approximately 0.11% of Integer worth $4,334,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Lee Danner & Bass Inc. acquired a new stake in Integer during the fourth quarter valued at approximately $27,000. Opal Wealth Advisors LLC acquired a new stake in Integer during the first quarter valued at approximately $28,000. AdvisorNet Financial Inc acquired a new stake in Integer during the first quarter valued at approximately $28,000. Bessemer Group Inc. raised its stake in Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 125 shares in the last quarter. Finally, Sterling Capital Management LLC raised its stake in Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after buying an additional 279 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Insiders Place Their Bets

In other news, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the transaction, the director owned 22,170 shares of the company's stock, valued at $2,672,815.20. This represents a 28.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the sale, the chief executive officer owned 47,000 shares of the company's stock, valued at approximately $5,788,990. This represents a 87.82% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 362,434 shares of company stock valued at $44,577,115. 2.16% of the stock is currently owned by corporate insiders.

Integer Stock Performance

Shares of Integer stock traded down $2.13 during trading on Friday, reaching $112.51. The company's stock had a trading volume of 463,003 shares, compared to its average volume of 389,860. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. The business's fifty day moving average price is $119.65 and its 200-day moving average price is $124.45. The firm has a market cap of $3.93 billion, a price-to-earnings ratio of 53.32, a price-to-earnings-growth ratio of 0.99 and a beta of 0.98. Integer Holdings Corporation has a one year low of $104.93 and a one year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.95% and a net margin of 4.38%. The company had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. During the same period in the prior year, the company posted $1.14 EPS. The company's revenue was up 7.3% compared to the same quarter last year. As a group, equities research analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ITGR. KeyCorp dropped their price target on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and increased their price objective for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Raymond James Financial increased their price objective on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Finally, Truist Financial set a $150.00 price objective on shares of Integer and gave the company a "buy" rating in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Integer currently has an average rating of "Moderate Buy" and an average price target of $146.25.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.